REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally-invasive treatment for patients with severe emphysema, announces a ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that UnitedHealthcare®, the largest commercial insurer in the United ...
Exclusive deal covers Australia, Canada, New Zealand, and the U.S. Baxter International is paying $20 million upfront to Kamada for exclusive commercial rights to Glassiaâ„¢, a liquid alpha1-proteinase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results